| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-05 12:40:53 UTC |
|---|
| Updated at | 2022-09-05 12:40:53 UTC |
|---|
| NP-MRD ID | NP0213635 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | carane |
|---|
| Description | Cis-Carane belongs to the class of organic compounds known as bicyclic monoterpenoids. These are monoterpenoids containing exactly 2 rings, which are fused to each other. Thus, cis-carane is considered to be an isoprenoid lipid molecule. Cis-Carane is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. carane is found in Aucoumea klaineana and Chrysopogon zizanioides. carane was first documented in 1981 (PMID: 7229954). A carbobicyclic compound that is bicycloheptane substituted by methyl groups at positions 3, 7 and 7 (PMID: 17192005) (PMID: 1492839) (PMID: 8083817) (PMID: 14664397) (PMID: 15525450) (PMID: 21441619). |
|---|
| Structure | InChI=1S/C10H18/c1-7-4-5-8-9(6-7)10(8,2)3/h7-9H,4-6H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Carane, (1S-(1alpha,3alpha,6alpha))-isomer | HMDB | | Carane, (1alpha,3beta,6alpha)-isomer | HMDB | | Carane, (1S-(1alpha,3beta,6alpha))-isomer | HMDB | | Carane, (1alpha,3alpha,6alpha)-isomer | HMDB | | (-)-cis-Carane | HMDB |
|
|---|
| Chemical Formula | C10H18 |
|---|
| Average Mass | 138.2540 Da |
|---|
| Monoisotopic Mass | 138.14085 Da |
|---|
| IUPAC Name | 3,7,7-trimethylbicyclo[4.1.0]heptane |
|---|
| Traditional Name | carane |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1CCC2C(C1)C2(C)C |
|---|
| InChI Identifier | InChI=1S/C10H18/c1-7-4-5-8-9(6-7)10(8,2)3/h7-9H,4-6H2,1-3H3 |
|---|
| InChI Key | BWRHOYDPVJPXMF-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as bicyclic monoterpenoids. These are monoterpenoids containing exactly 2 rings, which are fused to each other. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Monoterpenoids |
|---|
| Direct Parent | Bicyclic monoterpenoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Carane monoterpenoid
- Bicyclic monoterpenoid
- Polycyclic hydrocarbon
- Saturated hydrocarbon
- Hydrocarbon
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Ishida T, Asakawa Y, Takemoto T, Aratani T: Terpenoids biotransformation in mammals III: Biotransformation of alpha-pinene, beta-pinene, pinane, 3-carene, carane, myrcene, and p-cymene in rabbits. J Pharm Sci. 1981 Apr;70(4):406-15. doi: 10.1002/jps.2600700417. [PubMed:7229954 ]
- Ishida T: Biotransformation of terpenoids by mammals, microorganisms, and plant-cultured cells. Chem Biodivers. 2005 May;2(5):569-90. doi: 10.1002/cbdv.200590038. [PubMed:17192005 ]
- Czarnecki R, Czerwinska K, Grochowska K, Grochowski J, Librowski T, Serda P: Molecular structure and antiaggregating activity of the potent local anaesthetic (-)-4-[2-hydroxy-3-(N-isopropylamino)-propoxyimino]-cis-carane . Arzneimittelforschung. 1992 Nov;42(11):1279-83. [PubMed:1492839 ]
- Librowski T, Nalepa I, Czarnecki R, Vetulani J: The effect of (-)-4-(2-hydroxy-3(N-isopropylamino)-propoxyimino)-cis-carane on basal and forskolin-stimulated accumulation of cyclic AMP in the cerebral cortical slices of the rat. J Pharm Pharmacol. 1994 May;46(5):393-4. doi: 10.1111/j.2042-7158.1994.tb03823.x. [PubMed:8083817 ]
- Dang HS, Roberts BP, Tocher DA: Thiol-catalysed radical-chain redox rearrangement reactions of benzylidene acetals derived from terpenoid diols. Org Biomol Chem. 2003 Nov 21;1(22):4073-84. doi: 10.1039/b309060b. [PubMed:14664397 ]
- Librowski T, Vetulani J, Nalepa I: Carane derivative stereoisomers of different local anaesthetic and antiplatelet activity similarly potentiate forskolin-stimulated cyclic AMP response and bind to beta-adrenoceptors in the rat brain cortex. J Pharm Pharmacol. 2004 Nov;56(11):1429-34. doi: 10.1211/0022357044742. [PubMed:15525450 ]
- Moniczewski A, Librowski T, Lochynski S, Strub D: Evaluation of the irritating influence of carane derivatives and their antioxidant properties in a deoxyribose degradation test. Pharmacol Rep. 2011;63(1):120-9. doi: 10.1016/s1734-1140(11)70406-6. [PubMed:21441619 ]
- LOTUS database [Link]
|
|---|